We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 148.58 | 0 | 01:00:00 |
From May 2019 to May 2024
By Michael Wright
U.S. health authorities recommended a pause in the use of Johnson & Johnson's Covid-19 vaccine after reports of rare blood clotting in recipients of the shot based in the U.S.
The Food and Drug Administration said in a tweet Tuesday that it and the Centers for Disease Control and Prevention were reviewing data involving six reported cases of clotting.
The FDA said it was recommending a pause in the use of the J&J vaccine "out of an abundance of caution."
(END) Dow Jones Newswires
April 13, 2021 07:41 ET (11:41 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
